全球的體外診斷藥物(IVD)市場報告（2011年版） 是由出版商Koncept Analytics在2011年10月所出版的。
這份英文市場調查報告書包含48 Pages 價格從美金800起跳。
全球的體外診斷藥物市場沒有受到經濟危機的影響，反而由於新技術導入和全球各國高齡化的進展、新興國家市場的成長等而著實成長。以領域單位觀察，免疫化學與糖尿病治療相關佔了市場大幅比例。地區來說，北美・歐洲・日本佔了大半的市場，而亞太地區・中南美的各國則以高成長率現正緊追當中。
本報告，分析體外診斷用醫藥品(IVD)的全球市場，彙整整體市場結構和成長促進因素、法規架構、競爭環境、主要市場的動向、主要企業的檔案資料與策略等的情報，並推估今後的市場動向，由下列摘要形式闡述。
第1章 診斷市場
- 概要
- 體外診斷藥物(IVD)
- 體外診斷藥物的價值鏈
第2章 全球市場分析
第3章 體外診斷藥物的主要市場
- EU各國的體外診斷藥物市場
- 北美的體外診斷藥物市場
- 中國的體外診斷藥物市場
- 印度的體外診斷藥物市場
第4章 成長促進因素
- 新興國家市場的成長
- 部門別的成長
- 醫療費用支出的增加
- 維他命D測試的低普及率
- 高齡化人口的急增
- 對病患自身的、或是經濟面的優點
- 價格壓力的增大
- 糖尿病病患數的增加
- 醫療費用報銷的條件
第5章 法規架構
第6章 競爭環境
第7章 企業檔案資料
- Roche Holdings AG
- 事業內容
- 主要財務指標
- 事業策略
- 個人健康照護的提供
- 關注醫療上的未滿足需求
- 促進研發活動對策的加強
- Siemens AG
- 事業內容
- 主要財務指標
- 事業策略
- 醫療相關策略
- 致力於透過研發的創新
- Abbott Laboratories
- 事業內容
- 主要財務指標
- 事業策略
- 往新興市場的擴張
- 產品線的擴大
- 企業收購所導致的外部成長
- Beckman Coulter
第8章 市場展望
圖表一覽
Abstract
Description
In-vitro diagnostics (IVD), which includes testing from assays in a controlled
environment outside the living organism, accounts for a major share in the
global diagnostics market. Despite the global economic crisis, the market
registered growth mainly on the back of introduction of novel technologies,
rapidly ageing population, increasing health awareness, and increasing
contribution of the emerging countries.
On the basis of technology, Immunochemistry dominates the global IVD market,
followed by Diabetes Care. North America represents the largest IVD market
worldwide, followed by Europe and Japan. In the coming years, these mature
markets would offer less potential for growth, whereas the emerging markets
like Asia Pacific and Latin America would offer immense potential for growth.
Point of Care (POC), which offers diagnostic services at or near the site of
the patient, is more convenient than the traditional tests as it brings the
result immediately for fast and better treatment. Some of the other segments
which are likely to register significant growth rates in the coming years
include Molecular Diagnostics, and Anatomic Pathology. On the back of growth
in some of the aforementioned segments, coupled with the increasing healthcare
expenditure, rapidly ageing population, increasing diabetic population, as
well as the rising per capita income in the emerging countries, the IVD market
is expected to benefit in the years to come.
Global IVD industry is consolidated with the top nine players accounting for a
major share. In fact, the ongoing mergers and acquisitions in the industry are
expected to further increase consolidation. Roche is the market leader,
followed by Abbott, Siemens and Johnson & Johnson.
The current report entitled " Global In-vitro Diagnostics (IVD) Market: 2011
Edition" , presents the global market for in-vitro diagnostics as well as its
segments. The two leading IVD markets, European Union and North America as
well as the two emerging markets for IVD, India and China are being profiled
in the report. The report discusses the major drivers promising future growth.
Since the IVD industry is highly regulated, the regulatory structure, with a
focus on Europe and the US is also being discussed in the report. The major
players in the IVD industry have been profiled in this report, highlighting
their financials as well as strategies for growth.
By combining SPSS Inc.'s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the industry. We
employed various significant variables that have an impact on this industry
and created regression models with SPSS Base to determine the future direction
of the industry. Before deploying the regression model, the relationship
between several independent or predictor variables and the dependent variable
was analyzed using standard SPSS output, including charts, tables and tests.
Table of Contents
1. Diagnostics Market
- 1.1 Overview
- 1.2 In Vitro Diagnostic
- 1.3 IVD Value Chain
2. Global Market Analysis
- 2.1 Diagnostics Market
- Market Value
- Market Segments
- 2.2 IVD Market
- Market Value
- Major Regional Markets
- Market Segmentation
- by Application
- by Technology
- by Disease
- by Product Category
- by Location
3. Principal IVD Markets
- 3.1 European Union IVD Market
- Market Value
- Breakdown by Country
- 3.2 North America IVD Market
- 3.3 China IVD Market
- 3.4 India IVD Market
- Market Value
- Market Segments
4. Growth Drivers
- 4.1 Growth in Emerging Markets
- 4.2 Segmental Growth
- 4.3 Rising Healthcare Expenditure
- 4.4 Low Penetration of Vitamin D Tests
- 4.5 Rapidly Ageing Population
- 4.6 Significant Patient & Economic Benefits
- 4.7 Increasing Cost Pressures
- 4.8 Increasing Diabetes Population
- 4.9 Reimbursement Conditions
5. Regulatory Structure
6. IVD Market - Competitive Landscape
- 6.1 Overview
- 6.2 Consolidation in the IVD Market
7. Company Profiles
- 7.1 Roche Holdings AG
- Business Description
- Key Financials
- Business Strategies
- Providing Personalized Healthcare
- Focus on Unmet Medical Needs
- Increase in R&D Initiatives
- 7.2 Siemens AG
- Business Description
- Key Financials
- Business Strategies
- Healthcare Strategy
- Focusing on Innovation through R&D
- 7.3 Abbott Laboratories
- Business Description
- Key Financials
- Business Strategies
- Expansion in Emerging Markets
- Expanding Product Pipeline
- External Growth through Acquisitions
- 7.4 Beckman Coulter
- Business Description
- Key Financials
- Business Strategies
8. Market Outlook
- 8.1 Market Forecast
- 8.2 Forecast Methodology
- 8.2.1 Dependent and Independent Variables
- 8.2.2 Correlation Analysis
- 8.2.3 Regression Analysis
List of Charts
- IVD Market - Segments by Technology
- IVD Market - End Users
- IVD Value Chain Analysis in Medical Application
- Global Diagnostics Market (2005-2012E)
- Global Diagnostics Market - Value Share by Segments (2010)
- Global IVD Market (2005-2010)
- Top 10 IVD Markets - by Value (2010)
- Global IVD Market - Value Share by Application (2010)
- Global IVD Market-Segmentation by Technology (2009)
- Global IVD Market - Value Share by Type of Disease (2010)
- Global IVD Market - Value Share by Product Category (2010)
- Point of Care and Clinical Laboratory Testing Share in Global IVD Market
(2010E)
- Global IVD Market - Value Share by End Sites (2009)
- Global IVD Market - Value Share by Region (2010E)
- IVD Market in the European Union (2007-2009)
- IVD Market in the Europe - by Countries (2009)
- North American IVD Market (2010-2013E)
- US Diagnostic Testing Market (2010)
- China's IVD Market - Share Breakdown by Value (2010)
- Indian IVD Market (2008-2009)
- Indian IVD Market - Value Share by Segments (2009)
- Indian IVD Market - Growth by Segments (2009 over 2008)
- IVD Market Growth - CAGR by Region (2010-2015)
- IVD Market Growth - by Segments (2010-2015)
- Healthcare Expenditure Worldwide (2005-2012E)
- Vitamin D Tests Penetration - by Region (2009)
- US Vitamin D Tests Market (2009-2014E)
- Europe Vitamin D Tests Market (2009-2014E)
- Average Healthcare Spending Worldwide - by Age
- Ageing Population Worldwide - age >60 years (2005-2012E)
- Diabetic Population Worldwide - age 20-79 years (2005-2012E)
- Global IVD Market - Share Breakdown by Region (2010)
- Number of M&A Deals in IVD Sector Worldwide (2004-2008)
- Roche Holdings Revenue (2006-2010)
- Roche Revenue - Share by Segments (2010)
- Roche & Genetech-Share of Projects in R&D (Jan 2011)
- Roche and Genetech-Share of Projects in Phase III (Jan 11)
- Siemens AG Revenue (FY06-FY10)
- Siemens Revenue - Share by Segments (FY10)
- Abbott Laboratories Revenue (2006-2010)
- Abbott Laboratories Revenue - Share by Segments (2010)
- Beckman Coulter Revenue (2006-2010)
- Beckman Revenue - Share Breakdown by Segments (2010)
- Global In Vitro Diagnostics Market (2010-2015E)
List of Tables
- IVD Market Key Players-by Segments
- Country-wise Division of European IVD Market (2009)
- Top 10 M&A Deals in IVD Sector (2008)
- Selected M&A Deals in IVD Sector (early 2009)
- Recent M&A Activities in the IVD Market (Oct'10-Apr'11)
- Dependent & Independent Variables (2005 - 2010)
- Model Summary - Coefficient of Determination
- Regression Coefficients Output
